Orphan Drugs Market
1 Study Coverage
1.1 Orphan Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Orphan Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oncology
1.2.3 Gastrointestinal
1.2.4 Pulmonary
1.2.5 Neurology
1.2.6 Hematology
1.2.7 Cardio-vascular
1.2.8 Metabolic Disorders
1.2.9 Endocrinology
1.2.10 Infectious Diseases
1.2.11 Others
1.3 Market by Application
1.3.1 Global Orphan Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Orphan Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Orphan Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Orphan Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Orphan Drugs Sales by Region
2.4.1 Global Orphan Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Orphan Drugs by Region (2023-2028)
2.5 Global Orphan Drugs Revenue by Region
2.5.1 Global Orphan Drugs Revenue by Region (2017-2022)
2.5.2 Global Orphan Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Orphan Drugs Sales by Manufacturers
3.1.1 Global Top Orphan Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Orphan Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Orphan Drugs in 2021
3.2 Global Orphan Drugs Revenue by Manufacturers
3.2.1 Global Orphan Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Orphan Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Orphan Drugs Revenue in 2021
3.3 Global Orphan Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Orphan Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Orphan Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Orphan Drugs Sales by Type
4.1.1 Global Orphan Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Orphan Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Orphan Drugs Sales Market Share by Type (2017-2028)
4.2 Global Orphan Drugs Revenue by Type
4.2.1 Global Orphan Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Orphan Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Orphan Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Orphan Drugs Price by Type
4.3.1 Global Orphan Drugs Price by Type (2017-2022)
4.3.2 Global Orphan Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Orphan Drugs Sales by Application
5.1.1 Global Orphan Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Orphan Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Orphan Drugs Sales Market Share by Application (2017-2028)
5.2 Global Orphan Drugs Revenue by Application
5.2.1 Global Orphan Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Orphan Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Orphan Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Orphan Drugs Price by Application
5.3.1 Global Orphan Drugs Price by Application (2017-2022)
5.3.2 Global Orphan Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Orphan Drugs Market Size by Type
6.1.1 North America Orphan Drugs Sales by Type (2017-2028)
6.1.2 North America Orphan Drugs Revenue by Type (2017-2028)
6.2 North America Orphan Drugs Market Size by Application
6.2.1 North America Orphan Drugs Sales by Application (2017-2028)
6.2.2 North America Orphan Drugs Revenue by Application (2017-2028)
6.3 North America Orphan Drugs Market Size by Country
6.3.1 North America Orphan Drugs Sales by Country (2017-2028)
6.3.2 North America Orphan Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Orphan Drugs Market Size by Type
7.1.1 Europe Orphan Drugs Sales by Type (2017-2028)
7.1.2 Europe Orphan Drugs Revenue by Type (2017-2028)
7.2 Europe Orphan Drugs Market Size by Application
7.2.1 Europe Orphan Drugs Sales by Application (2017-2028)
7.2.2 Europe Orphan Drugs Revenue by Application (2017-2028)
7.3 Europe Orphan Drugs Market Size by Country
7.3.1 Europe Orphan Drugs Sales by Country (2017-2028)
7.3.2 Europe Orphan Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Orphan Drugs Market Size by Type
8.1.1 Asia Pacific Orphan Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Orphan Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Orphan Drugs Market Size by Application
8.2.1 Asia Pacific Orphan Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Orphan Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Orphan Drugs Market Size by Region
8.3.1 Asia Pacific Orphan Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Orphan Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Orphan Drugs Market Size by Type
9.1.1 Latin America Orphan Drugs Sales by Type (2017-2028)
9.1.2 Latin America Orphan Drugs Revenue by Type (2017-2028)
9.2 Latin America Orphan Drugs Market Size by Application
9.2.1 Latin America Orphan Drugs Sales by Application (2017-2028)
9.2.2 Latin America Orphan Drugs Revenue by Application (2017-2028)
9.3 Latin America Orphan Drugs Market Size by Country
9.3.1 Latin America Orphan Drugs Sales by Country (2017-2028)
9.3.2 Latin America Orphan Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Orphan Drugs Market Size by Type
10.1.1 Middle East and Africa Orphan Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Orphan Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Orphan Drugs Market Size by Application
10.2.1 Middle East and Africa Orphan Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Orphan Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Orphan Drugs Market Size by Country
10.3.1 Middle East and Africa Orphan Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Orphan Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Corporation Information
11.2.2 Bristol-Myers Squibb Company Overview
11.2.3 Bristol-Myers Squibb Company Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bristol-Myers Squibb Company Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bristol-Myers Squibb Company Recent Developments
11.3 Celgene
11.3.1 Celgene Corporation Information
11.3.2 Celgene Overview
11.3.3 Celgene Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Celgene Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Celgene Recent Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Corporation Information
11.4.2 F. Hoffmann-La Roche Overview
11.4.3 F. Hoffmann-La Roche Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 F. Hoffmann-La Roche Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 F. Hoffmann-La Roche Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Sanofi
11.6.1 Sanofi Corporation Information
11.6.2 Sanofi Overview
11.6.3 Sanofi Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Sanofi Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sanofi Recent Developments
11.7 Alexion Pharmaceuticals
11.7.1 Alexion Pharmaceuticals Corporation Information
11.7.2 Alexion Pharmaceuticals Overview
11.7.3 Alexion Pharmaceuticals Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Alexion Pharmaceuticals Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Alexion Pharmaceuticals Recent Developments
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Corporation Information
11.8.2 Eli Lilly and Company Overview
11.8.3 Eli Lilly and Company Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Eli Lilly and Company Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Eli Lilly and Company Recent Developments
11.9 Novo Nordisk
11.9.1 Novo Nordisk Corporation Information
11.9.2 Novo Nordisk Overview
11.9.3 Novo Nordisk Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Novo Nordisk Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Novo Nordisk Recent Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Corporation Information
11.10.2 AstraZeneca Overview
11.10.3 AstraZeneca Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 AstraZeneca Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 AstraZeneca Recent Developments
11.11 Eisai
11.11.1 Eisai Corporation Information
11.11.2 Eisai Overview
11.11.3 Eisai Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Eisai Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Eisai Recent Developments
11.12 Daiichi Sankyo Company
11.12.1 Daiichi Sankyo Company Corporation Information
11.12.2 Daiichi Sankyo Company Overview
11.12.3 Daiichi Sankyo Company Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Daiichi Sankyo Company Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Daiichi Sankyo Company Recent Developments
11.13 Bayer
11.13.1 Bayer Corporation Information
11.13.2 Bayer Overview
11.13.3 Bayer Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Bayer Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Bayer Recent Developments
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Corporation Information
11.14.2 GlaxoSmithKline Overview
11.14.3 GlaxoSmithKline Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 GlaxoSmithKline Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 GlaxoSmithKline Recent Developments
11.15 Merck & Co
11.15.1 Merck & Co Corporation Information
11.15.2 Merck & Co Overview
11.15.3 Merck & Co Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Merck & Co Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Merck & Co Recent Developments
11.16 Johnson & Johnson
11.16.1 Johnson & Johnson Corporation Information
11.16.2 Johnson & Johnson Overview
11.16.3 Johnson & Johnson Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Johnson & Johnson Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Johnson & Johnson Recent Developments
11.17 Biogen
11.17.1 Biogen Corporation Information
11.17.2 Biogen Overview
11.17.3 Biogen Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Biogen Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Biogen Recent Developments
11.18 Takeda
11.18.1 Takeda Corporation Information
11.18.2 Takeda Overview
11.18.3 Takeda Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Takeda Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Takeda Recent Developments
11.19 Amgen
11.19.1 Amgen Corporation Information
11.19.2 Amgen Overview
11.19.3 Amgen Orphan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Amgen Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Amgen Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Orphan Drugs Industry Chain Analysis
12.2 Orphan Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Orphan Drugs Production Mode & Process
12.4 Orphan Drugs Sales and Marketing
12.4.1 Orphan Drugs Sales Channels
12.4.2 Orphan Drugs Distributors
12.5 Orphan Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Orphan Drugs Industry Trends
13.2 Orphan Drugs Market Drivers
13.3 Orphan Drugs Market Challenges
13.4 Orphan Drugs Market Restraints
14 Key Findings in The Global Orphan Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Orphan Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Oncology
Table 3. Major Manufacturers of Gastrointestinal
Table 4. Major Manufacturers of Pulmonary
Table 5. Major Manufacturers of Neurology
Table 6. Major Manufacturers of Hematology
Table 7. Major Manufacturers of Cardio-vascular
Table 8. Major Manufacturers of Metabolic Disorders
Table 9. Major Manufacturers of Endocrinology
Table 10. Major Manufacturers of Infectious Diseases
Table 11. Major Manufacturers of Others
Table 12. Global Orphan Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 13. Global Orphan Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 14. Global Orphan Drugs Sales by Region (2017-2022) & (K Units)
Table 15. Global Orphan Drugs Sales Market Share by Region (2017-2022)
Table 16. Global Orphan Drugs Sales by Region (2023-2028) & (K Units)
Table 17. Global Orphan Drugs Sales Market Share by Region (2023-2028)
Table 18. Global Orphan Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 19. Global Orphan Drugs Revenue Market Share by Region (2017-2022)
Table 20. Global Orphan Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 21. Global Orphan Drugs Revenue Market Share by Region (2023-2028)
Table 22. Global Orphan Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 23. Global Orphan Drugs Sales Share by Manufacturers (2017-2022)
Table 24. Global Orphan Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 25. Global Orphan Drugs Revenue Share by Manufacturers (2017-2022)
Table 26. Orphan Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
Table 27. Global Orphan Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Orphan Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orphan Drugs as of 2021)
Table 29. Orphan Drugs Manufacturing Base Distribution and Headquarters
Table 30. Manufacturers Orphan Drugs Product Offered
Table 31. Date of Manufacturers Enter into Orphan Drugs Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Orphan Drugs Sales by Type (2017-2022) & (K Units)
Table 34. Global Orphan Drugs Sales by Type (2023-2028) & (K Units)
Table 35. Global Orphan Drugs Sales Share by Type (2017-2022)
Table 36. Global Orphan Drugs Sales Share by Type (2023-2028)
Table 37. Global Orphan Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 38. Global Orphan Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 39. Global Orphan Drugs Revenue Share by Type (2017-2022)
Table 40. Global Orphan Drugs Revenue Share by Type (2023-2028)
Table 41. Orphan Drugs Price by Type (2017-2022) & (USD/Unit)
Table 42. Global Orphan Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
Table 43. Global Orphan Drugs Sales by Application (2017-2022) & (K Units)
Table 44. Global Orphan Drugs Sales by Application (2023-2028) & (K Units)
Table 45. Global Orphan Drugs Sales Share by Application (2017-2022)
Table 46. Global Orphan Drugs Sales Share by Application (2023-2028)
Table 47. Global Orphan Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 48. Global Orphan Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 49. Global Orphan Drugs Revenue Share by Application (2017-2022)
Table 50. Global Orphan Drugs Revenue Share by Application (2023-2028)
Table 51. Orphan Drugs Price by Application (2017-2022) & (USD/Unit)
Table 52. Global Orphan Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
Table 53. North America Orphan Drugs Sales by Type (2017-2022) & (K Units)
Table 54. North America Orphan Drugs Sales by Type (2023-2028) & (K Units)
Table 55. North America Orphan Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 56. North America Orphan Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 57. North America Orphan Drugs Sales by Application (2017-2022) & (K Units)
Table 58. North America Orphan Drugs Sales by Application (2023-2028) & (K Units)
Table 59. North America Orphan Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 60. North America Orphan Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 61. North America Orphan Drugs Sales by Country (2017-2022) & (K Units)
Table 62. North America Orphan Drugs Sales by Country (2023-2028) & (K Units)
Table 63. North America Orphan Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 64. North America Orphan Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 65. Europe Orphan Drugs Sales by Type (2017-2022) & (K Units)
Table 66. Europe Orphan Drugs Sales by Type (2023-2028) & (K Units)
Table 67. Europe Orphan Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 68. Europe Orphan Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 69. Europe Orphan Drugs Sales by Application (2017-2022) & (K Units)
Table 70. Europe Orphan Drugs Sales by Application (2023-2028) & (K Units)
Table 71. Europe Orphan Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 72. Europe Orphan Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 73. Europe Orphan Drugs Sales by Country (2017-2022) & (K Units)
Table 74. Europe Orphan Drugs Sales by Country (2023-2028) & (K Units)
Table 75. Europe Orphan Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 76. Europe Orphan Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 77. Asia Pacific Orphan Drugs Sales by Type (2017-2022) & (K Units)
Table 78. Asia Pacific Orphan Drugs Sales by Type (2023-2028) & (K Units)
Table 79. Asia Pacific Orphan Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 80. Asia Pacific Orphan Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 81. Asia Pacific Orphan Drugs Sales by Application (2017-2022) & (K Units)
Table 82. Asia Pacific Orphan Drugs Sales by Application (2023-2028) & (K Units)
Table 83. Asia Pacific Orphan Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 84. Asia Pacific Orphan Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 85. Asia Pacific Orphan Drugs Sales by Region (2017-2022) & (K Units)
Table 86. Asia Pacific Orphan Drugs Sales by Region (2023-2028) & (K Units)
Table 87. Asia Pacific Orphan Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 88. Asia Pacific Orphan Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 89. Latin America Orphan Drugs Sales by Type (2017-2022) & (K Units)
Table 90. Latin America Orphan Drugs Sales by Type (2023-2028) & (K Units)
Table 91. Latin America Orphan Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 92. Latin America Orphan Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 93. Latin America Orphan Drugs Sales by Application (2017-2022) & (K Units)
Table 94. Latin America Orphan Drugs Sales by Application (2023-2028) & (K Units)
Table 95. Latin America Orphan Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 96. Latin America Orphan Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 97. Latin America Orphan Drugs Sales by Country (2017-2022) & (K Units)
Table 98. Latin America Orphan Drugs Sales by Country (2023-2028) & (K Units)
Table 99. Latin America Orphan Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 100. Latin America Orphan Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Orphan Drugs Sales by Type (2017-2022) & (K Units)
Table 102. Middle East and Africa Orphan Drugs Sales by Type (2023-2028) & (K Units)
Table 103. Middle East and Africa Orphan Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Orphan Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Orphan Drugs Sales by Application (2017-2022) & (K Units)
Table 106. Middle East and Africa Orphan Drugs Sales by Application (2023-2028) & (K Units)
Table 107. Middle East and Africa Orphan Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Orphan Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 109. Middle East and Africa Orphan Drugs Sales by Country (2017-2022) & (K Units)
Table 110. Middle East and Africa Orphan Drugs Sales by Country (2023-2028) & (K Units)
Table 111. Middle East and Africa Orphan Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 112. Middle East and Africa Orphan Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 113. Novartis Corporation Information
Table 114. Novartis Description and Major Businesses
Table 115. Novartis Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 116. Novartis Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Novartis Recent Developments
Table 118. Bristol-Myers Squibb Company Corporation Information
Table 119. Bristol-Myers Squibb Company Description and Major Businesses
Table 120. Bristol-Myers Squibb Company Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 121. Bristol-Myers Squibb Company Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Bristol-Myers Squibb Company Recent Developments
Table 123. Celgene Corporation Information
Table 124. Celgene Description and Major Businesses
Table 125. Celgene Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 126. Celgene Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Celgene Recent Developments
Table 128. F. Hoffmann-La Roche Corporation Information
Table 129. F. Hoffmann-La Roche Description and Major Businesses
Table 130. F. Hoffmann-La Roche Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 131. F. Hoffmann-La Roche Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. F. Hoffmann-La Roche Recent Developments
Table 133. Pfizer Corporation Information
Table 134. Pfizer Description and Major Businesses
Table 135. Pfizer Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 136. Pfizer Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Pfizer Recent Developments
Table 138. Sanofi Corporation Information
Table 139. Sanofi Description and Major Businesses
Table 140. Sanofi Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 141. Sanofi Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Sanofi Recent Developments
Table 143. Alexion Pharmaceuticals Corporation Information
Table 144. Alexion Pharmaceuticals Description and Major Businesses
Table 145. Alexion Pharmaceuticals Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 146. Alexion Pharmaceuticals Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Alexion Pharmaceuticals Recent Developments
Table 148. Eli Lilly and Company Corporation Information
Table 149. Eli Lilly and Company Description and Major Businesses
Table 150. Eli Lilly and Company Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 151. Eli Lilly and Company Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Eli Lilly and Company Recent Developments
Table 153. Novo Nordisk Corporation Information
Table 154. Novo Nordisk Description and Major Businesses
Table 155. Novo Nordisk Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 156. Novo Nordisk Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Novo Nordisk Recent Developments
Table 158. AstraZeneca Corporation Information
Table 159. AstraZeneca Description and Major Businesses
Table 160. AstraZeneca Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 161. AstraZeneca Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. AstraZeneca Recent Developments
Table 163. Eisai Corporation Information
Table 164. Eisai Description and Major Businesses
Table 165. Eisai Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 166. Eisai Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Eisai Recent Developments
Table 168. Daiichi Sankyo Company Corporation Information
Table 169. Daiichi Sankyo Company Description and Major Businesses
Table 170. Daiichi Sankyo Company Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 171. Daiichi Sankyo Company Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Daiichi Sankyo Company Recent Developments
Table 173. Bayer Corporation Information
Table 174. Bayer Description and Major Businesses
Table 175. Bayer Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 176. Bayer Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Bayer Recent Developments
Table 178. GlaxoSmithKline Corporation Information
Table 179. GlaxoSmithKline Description and Major Businesses
Table 180. GlaxoSmithKline Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 181. GlaxoSmithKline Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. GlaxoSmithKline Recent Developments
Table 183. Merck & Co Corporation Information
Table 184. Merck & Co Description and Major Businesses
Table 185. Merck & Co Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 186. Merck & Co Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 187. Merck & Co Recent Developments
Table 188. Johnson & Johnson Corporation Information
Table 189. Johnson & Johnson Description and Major Businesses
Table 190. Johnson & Johnson Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 191. Johnson & Johnson Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 192. Johnson & Johnson Recent Developments
Table 193. Biogen Corporation Information
Table 194. Biogen Description and Major Businesses
Table 195. Biogen Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 196. Biogen Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 197. Biogen Recent Developments
Table 198. Takeda Corporation Information
Table 199. Takeda Description and Major Businesses
Table 200. Takeda Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 201. Takeda Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 202. Takeda Recent Developments
Table 203. Amgen Corporation Information
Table 204. Amgen Description and Major Businesses
Table 205. Amgen Orphan Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 206. Amgen Orphan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 207. Amgen Recent Developments
Table 208. Key Raw Materials Lists
Table 209. Raw Materials Key Suppliers Lists
Table 210. Orphan Drugs Distributors List
Table 211. Orphan Drugs Customers List
Table 212. Orphan Drugs Market Trends
Table 213. Orphan Drugs Market Drivers
Table 214. Orphan Drugs Market Challenges
Table 215. Orphan Drugs Market Restraints
Table 216. Research Programs/Design for This Report
Table 217. Key Data Information from Secondary Sources
Table 218. Key Data Information from Primary Sources
List of Figures
Figure 1. Orphan Drugs Product Picture
Figure 3. Global Orphan Drugs Market Share by Type in 2021 & 2028
Figure 3. Oncology Product Picture
Figure 4. Gastrointestinal Product Picture
Figure 5. Pulmonary Product Picture
Figure 6. Neurology Product Picture
Figure 7. Hematology Product Picture
Figure 8. Cardio-vascular Product Picture
Figure 9. Metabolic Disorders Product Picture
Figure 10. Endocrinology Product Picture
Figure 11. Infectious Diseases Product Picture
Figure 12. Others Product Picture
Figure 13. Global Orphan Drugs Market Share by Application in 2021 & 2028
Figure 14. Hospital Pharmacies
Figure 15. Retail pharmacies
Figure 16. Others
Figure 17. Orphan Drugs Report Years Considered
Figure 18. Global Orphan Drugs Sales 2017-2028 (K Units)
Figure 19. Global Orphan Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 20. Global Orphan Drugs Revenue 2017-2028 (US$ Million)
Figure 21. Global Orphan Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 22. Global Orphan Drugs Sales Market Share by Region (2017-2022)
Figure 23. Global Orphan Drugs Sales Market Share by Region (2023-2028)
Figure 24. North America Orphan Drugs Sales YoY (2017-2028) & (K Units)
Figure 25. North America Orphan Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Europe Orphan Drugs Sales YoY (2017-2028) & (K Units)
Figure 27. Europe Orphan Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Orphan Drugs Sales YoY (2017-2028) & (K Units)
Figure 29. Asia-Pacific Orphan Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Latin America Orphan Drugs Sales YoY (2017-2028) & (K Units)
Figure 31. Latin America Orphan Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Middle East & Africa Orphan Drugs Sales YoY (2017-2028) & (K Units)
Figure 33. Middle East & Africa Orphan Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 34. The Orphan Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 35. The Top 5 and 10 Largest Manufacturers of Orphan Drugs in the World: Market Share by Orphan Drugs Revenue in 2021
Figure 36. Global Orphan Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 37. Global Orphan Drugs Sales Market Share by Type (2017-2028)
Figure 38. Global Orphan Drugs Revenue Market Share by Type (2017-2028)
Figure 39. Global Orphan Drugs Sales Market Share by Application (2017-2028)
Figure 40. Global Orphan Drugs Revenue Market Share by Application (2017-2028)
Figure 41. North America Orphan Drugs Sales Market Share by Type (2017-2028)
Figure 42. North America Orphan Drugs Revenue Market Share by Type (2017-2028)
Figure 43. North America Orphan Drugs Sales Market Share by Application (2017-2028)
Figure 44. North America Orphan Drugs Revenue Market Share by Application (2017-2028)
Figure 45. North America Orphan Drugs Sales Share by Country (2017-2028)
Figure 46. North America Orphan Drugs Revenue Share by Country (2017-2028)
Figure 47. U.S. Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 48. Canada Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. Europe Orphan Drugs Sales Market Share by Type (2017-2028)
Figure 50. Europe Orphan Drugs Revenue Market Share by Type (2017-2028)
Figure 51. Europe Orphan Drugs Sales Market Share by Application (2017-2028)
Figure 52. Europe Orphan Drugs Revenue Market Share by Application (2017-2028)
Figure 53. Europe Orphan Drugs Sales Share by Country (2017-2028)
Figure 54. Europe Orphan Drugs Revenue Share by Country (2017-2028)
Figure 55. Germany Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 56. France Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 57. U.K. Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 58. Italy Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 59. Russia Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. Asia Pacific Orphan Drugs Sales Market Share by Type (2017-2028)
Figure 61. Asia Pacific Orphan Drugs Revenue Market Share by Type (2017-2028)
Figure 62. Asia Pacific Orphan Drugs Sales Market Share by Application (2017-2028)
Figure 63. Asia Pacific Orphan Drugs Revenue Market Share by Application (2017-2028)
Figure 64. Asia Pacific Orphan Drugs Sales Share by Region (2017-2028)
Figure 65. Asia Pacific Orphan Drugs Revenue Share by Region (2017-2028)
Figure 66. China Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Japan Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. South Korea Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. India Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 70. Australia Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 71. Taiwan Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 72. Indonesia Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 73. Thailand Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 74. Malaysia Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 75. Philippines Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Latin America Orphan Drugs Sales Market Share by Type (2017-2028)
Figure 77. Latin America Orphan Drugs Revenue Market Share by Type (2017-2028)
Figure 78. Latin America Orphan Drugs Sales Market Share by Application (2017-2028)
Figure 79. Latin America Orphan Drugs Revenue Market Share by Application (2017-2028)
Figure 80. Latin America Orphan Drugs Sales Share by Country (2017-2028)
Figure 81. Latin America Orphan Drugs Revenue Share by Country (2017-2028)
Figure 82. Mexico Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 83. Brazil Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 84. Argentina Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 85. Middle East and Africa Orphan Drugs Sales Market Share by Type (2017-2028)
Figure 86. Middle East and Africa Orphan Drugs Revenue Market Share by Type (2017-2028)
Figure 87. Middle East and Africa Orphan Drugs Sales Market Share by Application (2017-2028)
Figure 88. Middle East and Africa Orphan Drugs Revenue Market Share by Application (2017-2028)
Figure 89. Middle East and Africa Orphan Drugs Sales Share by Country (2017-2028)
Figure 90. Middle East and Africa Orphan Drugs Revenue Share by Country (2017-2028)
Figure 91. Turkey Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 92. Saudi Arabia Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 93. U.A.E Orphan Drugs Revenue (2017-2028) & (US$ Million)
Figure 94. Orphan Drugs Value Chain
Figure 95. Orphan Drugs Production Process
Figure 96. Channels of Distribution
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed
Industry Market Size
